Lack of effect of topiramate for central pain

被引：23

作者：

Canavero, S ^{[1
]}

Bonicalzi, V ^{[1
]}

Paolotti, R ^{[1
]}

机构：

[1] Molinette Mauriziano Hosp, Dept Neurosci, Pain Relief Unit, Turin, Italy

来源：

NEUROLOGY | 2002年 / 58卷 / 05期

关键词：

D O I：

10.1212/WNL.58.5.831-a

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：831 / 832

页数：2

共 7 条

[1] The neurochemistry of central pain: evidence from clinical studies, hypothesis and therapeutic implications [J].

Canavero, S ;

Bonicalzi, V .

PAIN, 1998, 74 (2-3) :109-114

[2] Topiramate in trigeminal neuralgia: A randomized, placebo-controlled multiple crossover pilot study [J].

Gilron, I ;

Booher, SL ;

Rowan, JS ;

Max, MB .

CLINICAL NEUROPHARMACOLOGY, 2001, 24 (02) :109-112

[3] N of 1 randomised controlled trials of oral ketamine in patients with chronic pain [J].

Haines, DR ;

Gaines, SP .

PAIN, 1999, 83 (02) :283-287

[4] Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell culture [J].

McLean, MJ ;

Bukhari, AA ;

Wamil, AW .

EPILEPSIA, 2000, 41 :S21-S24

[5] Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy [J].

Petroff, OAC ;

Hyder, F ;

Mattson, RH ;

Rothman, DL .

NEUROLOGY, 1999, 52 (03) :473-478

[6]

ROWBOTHAM MC, 2001, BONICAS MANAGEMENT P, P1729

[7]

TAKANO M, 1999, 9 WORLD C PAIN SEATT, pP68

← 1 →